+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Breast Cancer"

Generic Oncology Sterile Injectable Market Report 2025 - Product Thumbnail Image

Generic Oncology Sterile Injectable Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Metastatic Breast Cancer Treatment Market Report 2025 - Product Thumbnail Image

Metastatic Breast Cancer Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Breast Cancer Diagnostics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Breast Cancer Diagnostics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 181 Pages
  • Global
From
HER2 Positive Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HER2 Positive Breast Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
HER2 Negative Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HER2 Negative Breast Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
From
ER Positive, HER2 Negative Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

ER Positive, HER2 Negative Breast Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
From
Triple Negative Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Triple Negative Breast Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Metastatic HER2 Positive Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic HER2 Positive Breast Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Outpatient Oncology Infusion Market Report 2025 - Product Thumbnail Image

Outpatient Oncology Infusion Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Loading Indicator

The Breast Cancer market is a subset of the Women's Health market, focusing on the diagnosis, treatment, and prevention of breast cancer. It includes a range of products and services, from medical devices and pharmaceuticals to patient education and support. Breast cancer is the most common cancer among women worldwide, and the market is driven by the need to improve early detection and treatment outcomes. The Breast Cancer market is highly competitive, with a range of players from large multinationals to small start-ups. Companies in the market include Roche, Novartis, AstraZeneca, Pfizer, Merck, and Johnson & Johnson, as well as smaller players such as Myriad Genetics, Genomic Health, and Natera. Show Less Read more